The central role of TFEB in the regulation of ALP activity made the transcription factor an attractive tool to treat lysosomal storage diseases, such as Alzheimer’s disease, amyotrophic lateral sclerosis, Gaucher disease, and Pompe’s disease [22,24,25,46,47,48]. The gene discussed is TFEB; the disease is Gaucher disease.